Literature DB >> 33801941

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism.

Juliana Gomez1, Zammam Areeb1, Sarah F Stuart1, Hong P T Nguyen1, Lucia Paradiso1, Ahmad Zulkifli1, Sonakshi Madan1, Vijay Rajagopal2, Magdalene K Montgomery3, Hui K Gan4, Andrew M Scott4, Jordan Jones1,5, Andrew H Kaye1,6, Andrew P Morokoff1,5, Rodney B Luwor1.   

Abstract

Reticulocalbin 1 (RCN1) is an endoplasmic reticulum (ER)-residing protein, involved in promoting cell survival during pathophysiological conditions that lead to ER stress. However, the key upstream receptor tyrosine kinase that regulates RCN1 expression and its potential role in cell survival in the glioblastoma setting have not been determined. Here, we demonstrate that RCN1 expression significantly correlates with poor glioblastoma patient survival. We also demonstrate that glioblastoma cells with expression of EGFRvIII receptor also have high RCN1 expression. Over-expression of wildtype EGFR also correlated with high RCN1 expression, suggesting that EGFR and EGFRvIII regulate RCN1 expression. Importantly, cells that expressed EGFRvIII and subsequently showed high RCN1 expression displayed greater cell viability under ER stress compared to EGFRvIII negative glioblastoma cells. Consistently, we also demonstrated that RCN1 knockdown reduced cell viability and exogenous introduction of RCN1 enhanced cell viability following induction of ER stress. Mechanistically, we demonstrate that the EGFRvIII-RCN1-driven increase in cell survival is due to the inactivation of the ER stress markers ATF4 and ATF6, maintained expression of the anti-apoptotic protein Bcl-2 and reduced activity of caspase 3/7. Our current findings identify that EGFRvIII regulates RCN1 expression and that this novel association promotes cell survival in glioblastoma cells during ER stress.

Entities:  

Keywords:  EGFRvIII; ER stress; RCN1; apoptosis; glioblastoma

Year:  2021        PMID: 33801941      PMCID: PMC7999088          DOI: 10.3390/cancers13061198

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  56 in total

1.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

2.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

Authors:  N Sugawa; A J Ekstrand; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIII.

Authors:  Anupama E Gururaj; Laura Gibson; Sonali Panchabhai; MingHui Bai; Ganiraju Manyam; Yue Lu; Khatri Latha; Marta L Rojas; Yeohyeon Hwang; Shoudan Liang; Oliver Bogler
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

4.  A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.

Authors:  M Nagane; F Coufal; H Lin; O Bögler; W K Cavenee; H J Huang
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

5.  Reticulocalbin-1 knockdown increases the sensitivity of cells to Adriamycin in nasopharyngeal carcinoma and promotes endoplasmic reticulum stress-induced cell apoptosis.

Authors:  Ze-Hao Huang; Jun Qiao; Yi-Yang Feng; Meng-Ting Qiu; Ting Cheng; Jia Wang; Chao-Feng Zheng; Zhi-Qin Lv; Cai-Hong Wang
Journal:  Cell Cycle       Date:  2020-05-21       Impact factor: 4.534

Review 6.  The EGFRvIII variant in glioblastoma multiforme.

Authors:  Hui K Gan; Andrew H Kaye; Rodney B Luwor
Journal:  J Clin Neurosci       Date:  2009-03-25       Impact factor: 1.961

7.  Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.

Authors:  D K Moscatello; M Holgado-Madruga; A K Godwin; G Ramirez; G Gunn; P W Zoltick; J A Biegel; R L Hayes; A J Wong
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

8.  PERK Regulates Glioblastoma Sensitivity to ER Stress Although Promoting Radiation Resistance.

Authors:  David Y A Dadey; Vaishali Kapoor; Arpine Khudanyan; Dinesh Thotala; Dennis E Hallahan
Journal:  Mol Cancer Res       Date:  2018-07-10       Impact factor: 5.852

9.  RCN1 suppresses ER stress-induced apoptosis via calcium homeostasis and PERK-CHOP signaling.

Authors:  S Xu; Y Xu; L Chen; Q Fang; S Song; J Chen; J Teng
Journal:  Oncogenesis       Date:  2017-03-20       Impact factor: 7.485

10.  Novel Curcumin Inspired Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death.

Authors:  Lorenzo Sansalone; Eduardo A Veliz; Nadia G Myrthil; Vasileios Stathias; Winston Walters; Ingrid I Torrens; Stephan C Schürer; Steven Vanni; Roger M Leblanc; Regina M Graham
Journal:  Cancers (Basel)       Date:  2019-03-13       Impact factor: 6.639

View more
  3 in total

Review 1.  Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin.

Authors:  Seyed Mehdi Havaei; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

2.  Reticulocalbin 1 is required for proliferation and migration of non-small cell lung cancer cells regulated by osteoblast-conditioned medium.

Authors:  Haijing Fu; Rui Chen; Yue Wang; Yang Xu; Chun Xia; Bing Zhang
Journal:  J Cell Mol Med       Date:  2021-11-07       Impact factor: 5.310

3.  Reticulocalbin3: A Ca2+ homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance.

Authors:  Rui Cai; Ping Wang; Xin Zhao; Xiansheng Lu; Ruxia Deng; Xiaoyu Wang; Chang Hong; Jie Lin
Journal:  Cancer Sci       Date:  2022-08-03       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.